![](https://webarchive.library.unt.edu/eot2008/20090514000224im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090514000224im_/http://www.cancer.gov/images/spacer.gif)
| A drug being studied in the treatment of acute leukemias and some other types of cancer. It binds to a protein that is present on the surface of some types of cancer cells and stops them from dividing. CEP-701 is a type of receptor tyrosine kinase inhibitor and a type of indolocarbazole alkaloid. Also called lestaurtinib. |
Previous Definitions: | central nervous system prophylaxis, central nervous system sanctuary therapy, central nervous system tumor, central venous access catheter, CEP-2563 dihydrochloride | Next Definitions: | cephalexin, cephalosporin, ceramide, cerebellar hemangioblastoma, cerebellopontine |
|
![](https://webarchive.library.unt.edu/eot2008/20090514000224im_/http://www.cancer.gov/images/spacer.gif) |